Traditional Chinese medicine for acute mountain sickness prevention: A systematic review and meta-analysis of randomized controlled trials

Objective: To evaluate the efficacy of traditional Chinese medicine(TCM) for preventing acute mountain sickness(AMS).Methods: We included randomized controlled trials(RCTs) which evalueded the effect of TCM for preventing AMS, compared with a placebo, no treatment or acetazolamide. The literature was searched in 6major databases. RevMan 5.4 software was used for the meta-analysis. The relative risk for discrete variables and the mean difference for continuous variables with 95% confidence intervals(CIs) were applied to express the effect size. The risk of bias in the included studies was evaluated using the Cochrane risk assessment tool 2.0(RoB 2.0), and the evidence certainty was assessed using the Grading of Recommendations Assessment and the Development and Evaluation(GRADE) approach.Results: Twenty RCTs involving 3015 participants and 16 TCM patent drugs were included. The overall risk of bias in the majority of studies(15/20) was of some concerns. In terms of the AMS incidence,Rhodiola rosea(R. rosea, Hong Jing Tian) and Ginkgo biloba(G. biloba, Yin Xing Ye) were equivalent to the placebo/no treatment [RR(95% CI): 0.66(0.43-1.01), 0.82(0.63-1.06), respectively]. The AMS incidence in the G. biloba group was higher than that in the acetazolamide group [RR(95% CI): 2.92(1.69-5.06)]. In terms of improving the AMS symptom score on days 1 and 3 in the plateau, R. rosea and G. biloba were superior to the placebo or no treatment [MD(95% CI):-0.98(-1.71,-0.25),-2.05(-3.14,-0.95), respectively]. The other 14 Chinese patent medicines were evaluated in a single trial, and the majority of the results were negative. The subgroup analysis showed that the effect of R. rosea was related to the intervention time, way of ascending, and altitude.Conclusion: R. rosea and G. biloba were effective in improving AMS symptoms but had no effect in reducing the AMS incidence. There was insufficient evidence to support the use of other TCM patent drugs to prevent AMS. More randomized double-blind placebo-controlled trials are warranted to evaluate and screen effective Chinese patent medicines for AMS prevention.

The Role of the“Traditional Chinese Medicine Proclamation”in Cholera Prevention and Control in Modern China

During the period of social transformation in modern China,the sudden onslaught of malignant infectious diseases,the helplessness of the public,and the impact of the modern Western medical system promoted the profound self‑revolution of traditional Chinese medicine(TCM).Multiple factors,including politics,economy or religion contributed to the formulation of paper-based“TCM proclamation”.This paper,based on the prevention and control of cholera advocated in TCM proclamation,analyzes the new ways of cholera spread in China in early modern times and the complicated“country‑region‑medical institutions‑other institutions‑individuals”correlations.

The Role of the “Traditional Chinese Medicine Proclamation” in Cholera Prevention and Control in Modern China

During the period of social transformation in modem China,the sudden onslaught of malignant infectious diseases,the helplessness of the public,and the impact of the modem Western medical system promoted the profoimd self-revolution of traditional Chinese medicine(TCM).Multiple factors,including politics,economy or religion contributed to the formulation of paper-based“TCM proclamation”.This paper,based on the prevention and control of cholera advocated in TCM proclamation,analyzes the new ways of cholera spread in China in early modem times and the complicated“country-region-medical instilulions-other institutions-individuals”correlations.

Overview of the plague in the late Ming Dynasty and its prevention and control measures

The plague of the late Ming Dynasty(15511644 C.E.)was long lasting,affected a wide range of the population,and had serious consequences.The purpose of this study is to review the medical system in place at the time and the measures instituted to prevent and control the plague during the late Ming Dynasty.Information on the history of the Ming Dynasty(13681644 C.E.),local chronicles,and related research literature were consulted and analyzed in terms of duration,geographical area,and other dimensions of the epidemic.Because of the abnormal climate,wide range of natural disasters,and the impact of war,the epidemic spread over a wide area during the late Ming Dynasty.The government’s epidemic prevention measures were affected by war and other factors,resulting in poor control of the outbreak.However,in terms of the medical system in place during the Ming Dynasty,some of the thinking and methods of prevention and control of the plague were historical and progressive.Some outstanding physicians such as Wu Youke(15821652 C.E.)appeared during this period.His theory of plague prevention and control had a profound influence on the formation and development of pestilence deterrence in later generations.In the late Ming Dynasty,rich experiences and measures of prevention and control were accumulated in the struggle against the plague.These methods and experiences also have a significant,positive guiding influence on the prevention and control of plague in the present day.

Discussion on the prevention and treatment of COVID-19 by Zhuang Medicine

The Corona Virus Disease 2019(COVID-19)spreads rapidly and is highly infectious.Zhuang Medicine,as a unique ancient and emerging ethnic medicine in Guangxi region,is combined with the unique local climate,geography and population physique,summing up many prevention and control experiences for infectious diseases,such as taking orally and external treatment,focusing on prevention.What is more,the Zhuang Medicine shows its own unique advantages through coming up with the measures of wearing medicine therapy,pyrotechnic fumigation,characteristic medicine baths and taking prescriptions internally.This paper intends to explore the use of Zhuang Medicine to build a disease prevention and control system with characteristics of Zhuang Medicine,trying to make a contribution to the prevention and control and treatment in this region.

State-of-the-art evidence of traditional Chinese medicine for treating coronavirus disease 2019

Traditional Chinese medicine has widely been used internationally in the treatment of coronavirus disease 2019(COVID-19)since January 2020.There has been great interest in initiating clinical studies testing different Chinese medicine therapies for COVID-19,but the majority of registered studies have yet to move forward due to a lack of COVID-19 patients in China's Mainland.The aim of this article was to systematically review the current clinical research evidence on Chinese medicine for treating COVID-19 from international and domestic bibliographic databases to reflect on the advances in this field.

Characteristics of 240 randomized controlled trials for adjusting constitution in preventive treatment of disease:A bibliometric analysis

Background:A growing number of randomized controlled trials(RCTs)have explored the significance of adjusting constitution for preventive treatment of disease in traditional Chinese medicine(TCM).In this study,we sought to comprehensively analyze the characteristics of these RCTs.Methods:All RCTs related to constitutional adjustment and preventive treatment of disease were included in the study.Literature was screened searching seven databases,including Pubmed,Web of Science,Embase,SinoMed,CNKI,Chongqing VIP,and Wangfang Database,from inception to December 2018.Data pertaining to bibliometrics,participants,and interventions were extracted and analyzed.Results:Two hundred and forty papers were published between 2007 and 2018,involving 240 RCTs with 55977 total participants.Sample size in these RCTs ranged from 30 to 7800.Among them,59 RCTs addressed disease prevention prior to onset involving 11 healthy states of participants,mainly for general health or sub-health population(40.68%)using health care and non-drug therapy.In control the development of existing disease(n Z 174),59 diseases were involved.Based on the number of RCTs and sample sizes,diseases including type 2 diabetes mellitus,primary hypertension,nonalcoholic fatty liver disease,and hyperlipoproteinemia accounted for 51.15%of the total patients studied.Drug therapy as an intervention was frequently used.In preventing recurrence after recovery(n Z 7),over 4 kinds of health status in participants were involved.Drug therapy combined with health care was mostly used.Most RCTs reported positive outcomes,with only one reporting negative findings(1/240).Conclusion:The number of RCTs of constitutional adjustment on preventive treatment of disease has gradually increased since 2012.Participants and intervention measures from the above-mentioned types of RCTs exhibit their own characteristics.Future systematic reviews or meta-analyses on constitutional adjustment for preventive treatment of disease are warranted.

Construction of competency evaluation system for infection control personnel in traditional Chinese medicine hospitals

Background:This study uses a literature review and the Delphi expert consultation method to construct a competency evaluation model for infection control personnel in traditional Chinese medicine(TCM)hospitals.The aim is to strengthen infection control management in TCM hospitals,assess the competency of infection control personnel in their positions,and assist them in identifying the competencies that need improvement.Methods:Based on the literature research method and the Delphi expert consultation method,a competency model for the position was constructed through two rounds of expert consultations,analyzing the relationships between various factors and establishing a hierarchical structure model.Pairwise comparisons were made among the elements at the same level to construct a judgment matrix.Through the analytic hierarchy process,the weight coefficients of the indicators at each level in the competency model were obtained.Results:This study conducted a comprehensive assessment of various capabilities and practices related to hospital infection control.The survey results indicate that participants excelled in multiple areas,with a high overall satisfaction rate.95.28%of participants were able to develop hospital infection monitoring plans based on national infection control policies,demonstrating a good understanding and execution of these policies.94.09%of participants were familiar with high-risk populations and key departments in the hospital.91.73%of participants were able to establish monitoring scopes based on the trends of multidrug-resistant bacteria and conduct information monitoring,reflecting strong response capabilities.92.91%of participants were able to collaborate with relevant departments to conduct bacterial resistance monitoring,showing a good team spirit.94.49%of participants were able to perform targeted monitoring,including surgical site infections,indicating that they have effective monitoring strategies.91.34%of participants were able to collect and organize monitoring data and establish a systematic database,demonstrating good data management skills.90.16%of participants were able to interpret laws and regulations related to hospital infection management,indicating a high level of legal knowledge.89.37%of participants generally possessed good communication skills.92.52%of participants were able to guide medical staff on occupational safety and protective knowledge,showing an emphasis on occupational health.Participants demonstrated a strong desire to learn and innovate,with 87.01%actively participating in continuing education and research activities,reflecting a pursuit of professional development.Conclusion:Based on the results of the two rounds of expert consultations,a competency evaluation model for infection control personnel in TCM hospitals was formed.Through the analytic hierarchy process,the weight coefficients of various indicators at different levels in the model were obtained,and the research results have good scientific validity and reliability.

The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19

The global coronavirus disease 2019(COVID-19)pandemic has had a massive impact on global social and economic development and human health.By combining traditional Chinese medicine(TCM)with modern medicine,the Chinese government has protected public health by supporting all phases of COVID-19 prevention and treatment,including community prevention,clinical treatment,control of disease progression,and promotion of recovery.Modern medicine focuses on viruses,while TCM focuses on differential diagnosis of patterns associated with viral infection of the body and recommends the use of TCM decoctions for differential treatment.This differential diagnosis and treatment approach,with its profoundly empirical nature and holistic view,endows TCM with an accessibility advantage and high application value for dealing with COVID-19.Here,we summarize the advantage of and evidence for TCM use in COVID-19 prevention and treatment to draw attention to the scientific value and accessibility advantage of TCM and to promote the use of TCM in response to public health emergencies.

Naoxintong Capsule for Secondary Prevention of Ischemic Stroke:A Multicenter,Randomized,and Placebo-Controlled Trial

Objective:To examine whether the combination of Naoxintong Capsule with standard care could further reduce the recurrence of ischemic stroke without increasing the risk of severe bleeding.Methods:A total of 23 Chinese medical centers participated in this trial.Adult patients with a history of ischemic stroke were randomlyassigned ina 1:1ratiousing a blockdesign toreceive eitherNaoxintong Capsule(1.2gorally,twice a day)or placebo in addition to standard care.The primary endpoint was recurrence of ischemic stroke within 2 years.Secondary outcomes included myocardial infarction,death due to recurrent ischemic stroke,and all-cause mortality.The safety of drugs was monitored.Results were analyzed using the intention-to-treat principle.

Non-pharmacological therapy of TCM for the treatment of essential hypertension

Non-pharmacotogicat treatment is an important means to control hypertension, with many advantages such as tow cost, tess medication, stable btood pressure, tess compHcations, and improved prognosis. This article reviews the research progress of non-drug treatment of hypertension in Chinese medicine in the past five years, and evaluates traditional Chinese medicine such as TCM Qigong, Wuhuo opera, Ba Duanjin and Taijiquan, and Chinese medicine acupuncture, moxibustion, massage, apptication, acupoint embedding and other traditional Chinese medicine. The effect of external treatment in hypertension control provides guidance for non-drug therapy to control hypertension.

公立医院加强中药配方颗粒廉政风险防控的研究和实践

近年来,随着中药配方颗粒市场的快速增长,相关的廉政风险也逐步凸显,公立医院必须高度重视,主动防范廉政风险。本文以上海市某三级甲等中医医院作为研究对象,从全面加强党风廉政建设、构建惩防体系、防患于未然的角度出发,梳理中药配方颗粒销售采购环节和临床应用环节的廉政风险点,通过加强廉政教育、完善管理制度、规范工作流程和运用“制度+科技”手段来强化监管等方式,建立健全中药配方颗粒廉政风险防控机制,有效管控廉政风险,促进公立医院高质量发展。

中药治疗再生障碍性贫血随机对照试验结局指标现状分析

目的:分析中药治疗再生障碍性贫血随机对照试验(RCTs)结局指标的使用现状,为构建中药治疗再生障碍性贫血的核心指标集研究提供参考。方法:检索中国知网(CNKI)、万方(Wanfang Data)、PubMed、Cochrane Library和Embase数据库,同时检索中国临床试验注册中心(ChiCTR)和Clinical Trials.gov收录的中药治疗再生障碍性贫血的研究,根据纳入标准筛选文献,评价纳入研究的偏倚风险,统计各结局指标的使用情况。结果:共纳入326项RCTs,样本量5~1 222例,共报告198个结局指标,应用总频数为2 020。结局指标按照功能属性可归到7个指标域中,包括中医病证、症状体征、理化检测、生活质量、远期预后、经济学评估和安全性事件,其中有效率、中医证候积分作为高频结局指标(分别报告了302次和52次),是中药治疗再生障碍性贫血核心结局指标的首要选择,其次应重点考虑的是中医证候有效率、不良反应、生活质量评分、生存质量。结论:中药治疗再生障碍性贫血RCTs在结局指标的使用方面存在着中医证型的诊断标准欠规范、临床疗效的评价标准不统一、指标种类多、指标数量及应用频数差异大、中医特色指标不足等诸多问题,尽快构建中药治疗再生障碍性贫血的核心指标集对推动中药治疗再生障碍性贫血临床研究具有深远的影响。

中医药与国家形象自塑研究

中医药是中华优秀传统文化的代表元素之一,在政府推动下,中医药越来越受到重视,其疗效也得到国内外民众的认可,中医药在塑造国家形象中的作用愈加明显。中医药服务贸易的增长和中医药在疫情防控中的突出表现证实了其疗效确切,有力回击了国外个别媒体“污名化”的报道,对国家形象的自塑起到积极作用。在翻译中准确阐释中医药理论及其疗效,增强文化自信,能为中医药塑造国家形象搭建桥梁。

门诊中药房中药饮片调剂差错原因分析及防范措施研究

分析门诊中药房中药饮片调剂差错的发生原因及防范措施。选取2022年8月—2023年8月盐城市中医院门诊中药房出现的82例中药饮片调剂差错事件,对差错原因进行分析,并提出防范对策。结果显示,82例门诊中药房中药饮片调剂差错事件中包含处方审方差错1例,药品漏配46例,药品错配11例,药品多配两例,剂量误差20例,药品发错两例。研究发现,门诊中药房中药饮片调剂差错出现的原因比较复杂,医院应加大对门诊中药房调剂人员的培训力度,提高处方开具规范性,加强处方监督,合理排班,从而降低门诊中药房中药饮片调剂差错率。

下肢骨折深静脉血栓防治的研究进展

深静脉血栓形成(deep vein thrombosis,DVT)是下肢骨折术后的常见并发症,具有高发病率、高致残率、高死亡率等特点。目前临床上防治下肢骨折术后深静脉血栓的措施主要包括围手术期护理、医疗辅助器械干预、西药干预、中医干预、患者自身配合等。患者自身配合是一切防治方法顺利实施的基础,患者的积极合作是实现防治作用的前提。围手术期护理有助于患者了解术后DVT的危险因素及DVT发生后可能引起的危险性,指导患者饮食的选择,协助患者术后活动,进而改善患者血液流变学指标水平,减少术后DVT的发生。医疗器械可协助患者进行术后康复锻炼,改善血液动力学水平,促进患者康复及减少术后DVT的发生。西药如低分子肝素、利伐沙班、依诺肝素等抗凝药物可降低凝血因子的聚集及血液黏稠度,减少术后DVT的发生。中医干预主要包括中药内服及外治法如针灸、推拿等。中药内服可改善血流状态;针灸、推拿可调动脏腑功能,激发机体的正气而改善机体气血情况。各项防治措施都有其优缺点,临证运用时需结合具体条件及患者个体状况而选择合理的防治方式。中医干预DVT可在下肢骨折患者的术前及术后执行,且具有费用低、效果确切等特点,值得不断挖掘及传承创新。

中草药饲料添加剂在养猪生产中的应用研究进展

中草药具有毒副作用小、耐药性较低、产品残留量低、经济环保且高效安全的优点,是在抗生素逐渐被限制使用后养猪生产上优秀的“替抗”饲料添加剂。文章从中草药饲料添加剂对生猪免疫机能、疾病防控、生长性能和繁殖性能影响等方面阐述了中草药饲料添加剂在养猪生产上的应用及优势,以期为生产实践提供指导。

手足综合征的中西医防治概况

手足综合征是肿瘤患者接受化疗或分子靶向治疗后出现的特异性皮肤毒性反应,以手足皮肤红肿、疼痛、脱屑、溃疡,伴麻木、疼痛等感觉异常为特点。手足综合征的中医疗法以口服汤药、中药浸洗为主,辅以针灸等非药物手段;西医疗法则以药物对症处理为主,如控制炎症、改善血供,同时配合健康宣教、剂量控制等综合措施。研究发现,中西医防治手足综合征存在相似的作用机制,中西医联合治疗手足综合征有望成为一种可靠选择。参考文献69篇。

蒽环类药物心脏毒性的中西药防治策略

蒽环类药物的心脏毒性对其临床使用造成极大限制,为探究蒽环类心脏毒性的规律及中西药防治策略,本文通过文献检索对蒽环类药物心脏毒性的发生机制和防治药物进行了归纳总结,其机制可分氧化应激、炎性反应、心肌细胞自噬以及DNA损伤4大类。防治药物西药以右丙亚胺、ACEI、ARB等为主,中药可分为单药、经方及中成药。在此基础上,对联合用药防治心脏毒性进行了讨论,介绍了西药、中药及中西药联合应用的理论依据及研究现状,结果表明其具有良好的可行性和安全性,可为临床上蒽环类化疗药物心脏毒性的防治策略研究提供参考。

中西医防控儿童轻中度近视的研究进展

随着近视日趋低龄化发展,防控工作的重点应前移至低龄儿童。本文通过回顾近年来中、西医防控低龄儿童(<11岁)轻、中度近视的研究,发现西医防控手段可一定程度上控制近视进展,但效果不够理想,且存在微生物性角膜炎、角膜溃疡等安全问题。以推拿、针灸、中药等为代表的中医适宜技术具有绿色安全、远期疗效相对稳定的特点,有利于弥补西医防控效果的不足,增强儿童近视防控的疗效与安全。